EAPH — Parallel Industries Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $2.48m
Annual income statement for Parallel Industries, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2011 December 31st | 2012 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | 10-K | 10-K | 10-K |
Standards: | — | — | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.379 | 1.56 | 0 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0.107 | 0.2 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 0.113 | 0.183 | 0.503 | 1.88 | 0.189 |
Operating Profit | -0.113 | -0.183 | -0.124 | -0.323 | -0.189 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.113 | -0.183 | -0.169 | -0.323 | -0.189 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.113 | -0.183 | -0.169 | -0.323 | -0.189 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.113 | -0.183 | -0.169 | -0.323 | -0.189 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.113 | -0.183 | -0.169 | -0.323 | -0.189 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | -0.002 | -0 | -0 | -0 |
Dividends per Share |